Does above-range IgG with normal IgM and negative PCR indicate prior antigen recognition rather than a diagnosis of active infection?

In a 77-year-old man, broad microbial-panel IgG elevations should be interpreted as evidence of immune recognition, not as a diagnosis of ongoing infection. This applies particularly when IgM is normal and PCR is negative in the specimen tested.

Clinical interpretation

• Pathogen-specific IgG reflects an adaptive immune response and often persists long after clearance. For EBV, VCA and EBNA IgG can persist for life; high titers do not date infection or establish reactivation.
• Normal/negative IgM and negative PCR make acute infection less supported, but do not rule it out in every circumstance.
• A single IgG result cannot distinguish remote exposure from persistent or reactivated infection. This is relevant across EBV, Babesia, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Coxsackievirus testing.
• For Babesia microti, antibodies may remain detectable for at least a year. A negative blood PCR indicates no parasite DNA detected in that blood specimen at that time, not necessarily absence of infection in all clinical contexts.

Mechanistic and testing considerations

• IgG-producing adaptive immune responses can remain detectable after pathogen clearance; thus antibody persistence is biologically expected and is not direct evidence of viable organisms.
• PCR/NAAT detects pathogen nucleic acid rather than immune memory, but its result depends on the organism, assay, specimen, timing, and disease compartment. Negative testing is therefore context-specific.
• When acute respiratory infection is suspected, PCR/NAAT is preferred for C. pneumoniae and M. pneumoniae; a single IgG cannot establish acute infection. For Coxsackievirus, paired samples showing a fourfold antibody rise are more informative than isolated IgG.

Bottom line

• Above-range IgG with normal IgM and negative PCR supports prior antigen recognition, but alone cannot determine whether findings represent remote exposure, persistence, or reactivation; clinically appropriate, organism-specific direct testing and the clinical syndrome must guide interpretation.